Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction

ST-segment elevation myocardial infarction (STEMI) represents the most urgent condition for patients with coronary artery disease. Prompt diagnosis and therapy, mainly with primary angioplasty using stents, are important in improving not only acute survival but also long-term prognosis. Recent advan...

Full description

Saved in:
Bibliographic Details
Main Author: Mun K. Hong
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Scientifica
Online Access:http://dx.doi.org/10.6064/2012/683683
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850171617418674176
author Mun K. Hong
author_facet Mun K. Hong
author_sort Mun K. Hong
collection DOAJ
description ST-segment elevation myocardial infarction (STEMI) represents the most urgent condition for patients with coronary artery disease. Prompt diagnosis and therapy, mainly with primary angioplasty using stents, are important in improving not only acute survival but also long-term prognosis. Recent advances in angioplasty devices, including manual aspiration catheters and drug-eluting stents, and pharmacologic therapy, such as potent antiplatelet and anticoagulant agents, have significantly enhanced the acute outcome for these patients. Continuing efforts to educate the public and to decrease the door-to-balloon time are essential to further improve the outcome for these high-risk patients. Future research to normalize the left ventricular function by autologous stem cell therapy may also contribute to the quality of life and longevity of the patients surviving STEMI.
format Article
id doaj-art-99cfcd6e95d24afd8b7bf72ddecbf19f
institution OA Journals
issn 2090-908X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Scientifica
spelling doaj-art-99cfcd6e95d24afd8b7bf72ddecbf19f2025-08-20T02:20:15ZengWileyScientifica2090-908X2012-01-01201210.6064/2012/683683683683Recent Advances in the Treatment of ST-Segment Elevation Myocardial InfarctionMun K. Hong0Cardiac Catheterization Laboratory and Interventional Cardiology, St. Luke’s-Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, NY 10025, USAST-segment elevation myocardial infarction (STEMI) represents the most urgent condition for patients with coronary artery disease. Prompt diagnosis and therapy, mainly with primary angioplasty using stents, are important in improving not only acute survival but also long-term prognosis. Recent advances in angioplasty devices, including manual aspiration catheters and drug-eluting stents, and pharmacologic therapy, such as potent antiplatelet and anticoagulant agents, have significantly enhanced the acute outcome for these patients. Continuing efforts to educate the public and to decrease the door-to-balloon time are essential to further improve the outcome for these high-risk patients. Future research to normalize the left ventricular function by autologous stem cell therapy may also contribute to the quality of life and longevity of the patients surviving STEMI.http://dx.doi.org/10.6064/2012/683683
spellingShingle Mun K. Hong
Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction
Scientifica
title Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction
title_full Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction
title_fullStr Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction
title_full_unstemmed Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction
title_short Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction
title_sort recent advances in the treatment of st segment elevation myocardial infarction
url http://dx.doi.org/10.6064/2012/683683
work_keys_str_mv AT munkhong recentadvancesinthetreatmentofstsegmentelevationmyocardialinfarction